Man Group’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-197,748
| Closed | -$303K | – | 1918 |
|
|
2025
Q1 | $303K | Buy |
197,748
+144,214
| +269% | +$221K | ﹤0.01% | 1710 |
|
|
2024
Q4 | $133K | Buy |
+53,534
| New | +$133K | ﹤0.01% | 1756 |
|
|
2024
Q3 | – | Sell |
-118,459
| Closed | -$130K | – | 1805 |
|
|
2024
Q2 | $130K | Sell |
118,459
-129,216
| -52% | -$142K | ﹤0.01% | 1800 |
|
|
2024
Q1 | $307K | Buy |
247,675
+146,395
| +145% | +$182K | ﹤0.01% | 1801 |
|
|
2023
Q4 | $106K | Buy |
+101,280
| New | +$106K | ﹤0.01% | 1851 |
|
|
2023
Q3 | – | Sell |
-133,036
| Closed | -$1.38M | – | 1422 |
|
|
2023
Q2 | $1.38M | Buy |
+133,036
| New | +$1.38M | ﹤0.01% | 1276 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1620 |
|
|
2020
Q3 | – | Sell |
-93,518
| Closed | -$151K | – | 1760 |
|
|
2020
Q2 | $151K | Hold |
93,518
| – | – | ﹤0.01% | 1609 |
|
|
2020
Q1 | $97K | Sell |
93,518
-1,202,448
| -93% | -$1.25M | ﹤0.01% | 1505 |
|
|
2019
Q4 | $2.45M | Sell |
1,295,966
-2,438,827
| -65% | -$4.61M | 0.01% | 1272 |
|
|
2019
Q3 | $4.03M | Buy |
3,734,793
+1,676,857
| +81% | +$1.81M | 0.02% | 964 |
|
|
2019
Q2 | $4.51M | Buy |
2,057,936
+872,408
| +74% | +$1.91M | 0.02% | 987 |
|
|
2019
Q1 | $7.1M | Buy |
1,185,528
+519,098
| +78% | +$3.11M | 0.03% | 735 |
|
|
2018
Q4 | $4.93M | Buy |
666,430
+263,806
| +66% | +$1.95M | 0.02% | 766 |
|
|
2018
Q3 | $5.85M | Buy |
402,624
+321,458
| +396% | +$4.67M | 0.02% | 891 |
|
|
2018
Q2 | $1.62M | Buy |
+81,166
| New | +$1.62M | 0.01% | 1433 |
|